Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular targeted drugs against ALK fusions].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 1 Jul 2011

Mano Hiroyuki

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Crizotinib
Share to Drug Resistance, Neoplasm
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to Pathology, Molecular

Share to Pyrazoles

Share to Pyridines

Source

Identifiers

PMID: 21747201
DOI: 10.1254/fpj.138.3

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular targeted drugs against ALK fusions].PMID 21747201Read ↗

Targeting drug-resistant mutations in ALK.Semantic proximity Read ↗

EML4-ALK: Update on ALK InhibitorsSemantic proximity Read ↗

New perspectives for targeting therapy in ALK-positive human cancersSemantic proximity Read ↗

ALK gene alterations in cancer: biological aspects and therapeutic implications.Semantic proximity Read ↗

RET-oncogene-targeting drugs draw notice.Semantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenarioSemantic proximity Read ↗

[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].Semantic proximity Read ↗

A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.Semantic proximity Read ↗

Targeting oncogenic ALK: a promising strategy for cancer treatment.Semantic proximity Read ↗

ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy.Semantic proximity Read ↗

EGFR antagonists in cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.